First Generic Ropinirole, Approved by The FDA
Filed in archive FDA Approvals , Neurological Disorders , Treatment by Gloria Gamat on May 9, 2008

© Brymo
From the NINDS-NIH:
Restless legs syndrome (RLS) is a neurological disorder characterized by unpleasant sensations in the legs and an uncontrollable urge to move when at rest in an effort to relieve these feelings. RLS sensations are often described by people as burning, creeping, tugging, or like insects crawling inside the legs. Often called paresthesias (abnormal sensations) or dysesthesias (unpleasant abnormal sensations), the sensations range in severity from uncomfortable to irritating to painful.
Now the FDA has approved the generic versions of Requip - Ropinirole Hydrochloride. The said generics approved are from the following generic drug
makers:- Roxane Laboratories Inc.
- Teva Pharmaceuticals USA
- Par Pharmaceuticals Inc.
- Mylan Pharmaceuticals Inc.
Read more from the FDA News.
Permalink: First Generic Ropinirole, Approved by The FDA
Tags:
Requip
Ropinirole
Hydrochloride
Restless
Legs
Syndrome
health
contact+lenses
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/122932

Mr Wong

